Weight loss injections in Sheffield: what they are, how they work, and whether one is right for you

Both licensed weight loss injections in the UK work through gut-hormone pathways that reduce appetite and slow gastric emptying, they are not stimulants or fat-dissolving compounds.
Mounjaro activates two receptors (GIP and GLP-1); Wegovy activates one (GLP-1), the distinction matters when a prescriber weighs them against your health history.
Treatment starts at a low tolerability dose and is stepped up gradually by your prescriber, typically in four-week intervals, to reduce gastrointestinal side effects.
Every pen is a once-weekly subcutaneous injection given at home; the technique is straightforward, but your prescriber or the Patient Information Leaflet will walk you through it the first time.

If you live in Sheffield and want a clear, honest account of weight loss injections — what they actually are, which ones are licensed in the UK, and how to access them safely — this page covers all of it. Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines approved for weight management in UK adults who meet clinical criteria; neither is available without a prescription following a proper clinical assessment. A registered prescriber decides suitability, not a website form. These are genuine medicines with a substantial evidence base, and understanding how they work before you start is worth the ten minutes it takes.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The practical detail Sheffield residents most often ask about: mechanism, eligibility, side effects, and what reaching your door actually looks like

How do these injections actually work inside your body?

The two licensed weight loss injections work through your gut hormones, not willpower. After eating, your gut naturally releases hormones called GLP-1 and GIP that signal fullness to your brain and regulate how quickly your stomach empties. In people living with obesity, those signals are often blunted. Both Mounjaro and Wegovy amplify them artificially, which is why most people on treatment find their appetite falls noticeably within the first few weeks.

Wegovy contains semaglutide, a GLP-1 receptor agonist. It mimics a single gut hormone. Mounjaro contains tirzepatide, which is the only dual GIP-and-GLP-1 receptor agonist licensed for weight management in the UK, it acts on both pathways simultaneously. The NHS medicines page for tirzepatide explains the mechanism in plain terms if you want a more detailed read.

The consequence of slowed gastric emptying is that food stays in your stomach longer, reinforcing the fullness signal. That is also why nausea is the most reported side effect, particularly in the first few weeks or after a dose increase. It is not a sign something has gone wrong; it is the medicine doing what it is supposed to do, with your digestive system adjusting to a new rhythm. The effect typically settles. You can read a broader overview of the injectable options available on the weight loss injections page if you want to compare them side by side before going further.

Does Sheffield's NHS prescribe weight loss injections, and if not, what are the alternatives?

NHS access to these medicines in England is phased and criteria-based. NICE's guidance on tirzepatide (TA1026, published December 2024) recommends it for adults with a BMI of 35 or above plus at least one weight-related condition such as high blood pressure, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The NHS rollout has been structured in cohorts: the most complex patients (BMI 40-plus, four or more qualifying conditions) gained access from June 2025; the next cohort opened in June 2026. Even when you meet the criteria, your GP's practice needs to have opted into the prescribing programme, and access varies across Sheffield's ICB area.

Wegovy (semaglutide) is recommended by NICE for NHS use through specialist weight management services only, and waiting lists for those services are long in most parts of the country. The NHS England overview of weight management injections sets out the access criteria and wraparound support requirements clearly.

For people who do not meet the NHS thresholds, or who would rather not wait, the private route is a regulated online pharmacy with a GPhC-registered prescriber. That prescriber follows the same licensed eligibility criteria (BMI of 30 or above, or 27 or above with a weight-related condition) and must make a clinical judgement about your individual suitability. If you are curious about how hospital-based private providers structure their programmes, you can find out more about how Nuffield Health approaches weight loss injections, and the weight loss injections Wakefield page covers a comparable city-level picture for a nearby area.

What side effects should Sheffield patients know about before starting?

The side effect profile for both injections is dominated by the gut: nausea, loose stools or constipation, indigestion, burping, and in some people vomiting. Most people experience at least mild GI symptoms when they start or move up a dose. The slow titration schedule exists precisely to reduce this, starting at 2.5 mg for Mounjaro or 0.25 mg for Wegovy and stepping up gradually gives your body time to adjust.

Less common but worth knowing: headache, fatigue, dizziness, and injection-site reactions (redness, itching, bruising at the site). Rotating your injection site between your abdomen, thigh, and upper arm each week helps with the latter.

The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as an infrequent but serious risk associated with GLP-1 medicines. If you develop severe abdominal pain that radiates to your back, with or without vomiting, seek urgent medical help and tell the clinician you are on a GLP-1 medicine. You can report any suspected side effects directly through the MHRA's Yellow Card scheme. These medicines are not suitable during pregnancy, while breastfeeding, or for anyone under 18. A prescriber will go through contraindications with you as part of any proper clinical assessment.

One detail many people do not think to ask about: if you take the oral contraceptive pill and you are starting tirzepatide specifically, you should use an additional non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because the pill's absorption may be affected. Semaglutide does not carry the same advisory. The generic names for weight loss injections page has more on how the two medicines differ chemically, which is useful context for this kind of question.

What does the treatment actually look like once it arrives?

Each pen arrives by tracked DPD courier in a plain, unbranded box, nothing on the outside signals what is inside. Inside that box is a refrigerated Kwikpen (Mounjaro) or pre-filled syringe pen (Wegovy), each holding four weekly doses. You store it in the fridge at 2 to 8 degrees Celsius until you open it, then follow the exact storage guidance in your Patient Information Leaflet for how long it can stay at room temperature once in use. The leaflet is the authority on this; never go by a summary you found online.

Injection technique is simpler than most people expect. A short, thin needle goes just under the skin (not into muscle) at a 90-degree angle. Clean the site with an alcohol swab, pinch if you are using a lean site, inject, hold for a few seconds, withdraw. For anyone who finds needle disposal a hassle, a 1-litre sharps container is available through the pharmacy and keeps disposal straightforward and safe.

If you want to understand the broader cost picture before booking anything, the weight loss injections cost page gives an honest breakdown of what private treatment typically involves and what a headline price often omits. For a full picture of what is covered in one transparent price at a regulated online pharmacy (consultation, prescription, delivery, and aftercare) the treatments overview is the place to start. Speak to our prescribers if you have questions before committing to anything; that conversation costs nothing.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions